Ballentine Carter, M.D., Director of Adult Urology at the Brady Urological Institute, comments on expectant management of prostate cancer.

Ballentine Carter, M.D., Director of Adult Urology at the Brady Urological Institute, comments on expectant management of prostate cancer.

   Listen to podcast now

Program Notes:

0:20   What expectant management is no
1:15   Active surveillance
2:20   Try to predict disease that was small and low grade
3:17   Criteria based on biopsy findings
4:26    Carefully entered into database
5:30    Now has over 500 men ever enrolled
6:17   Accepted today for low risk disease
7:13    PSA velocity looks interesting
8:13   EPCA2 looks like a marker
9:05   Greatest hope is a panel of biomarkers
10:01 End

Additional Johns Hopkins Podcasts